Cargando...

Inhibition of antigen presentation during AAV gene therapy using virus peptides

The clinical trial using adeno-associated virus (AAV) vector delivery of mini-dystrophin in patients with Duchenne Muscular Dystrophy (DMD) demonstrated a cytotoxic lymphocyte (CTL) response targeting the transgene product. These mini-dystrophin-specific T-cells have the potential to clear all trans...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hum Mol Genet
Autores principales: Shao, Wenwei, Chen, Xiaojing, Samulski, Richard J, Hirsch, Matthew L, Li, Chengwen
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5886241/
https://ncbi.nlm.nih.gov/pubmed/29272432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddx427
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!